Main Topic: The podcast episode discusses the potential medical applications of psychedelics, specifically ibogaine, in treating addiction and mental health disorders.
Key Points:
Participants:
Takeaways:
Sound of a news theme plays
John Bickley
Welcome to Morning Wire, I'm John Bickley, Editor-in-Chief of the Daily Wire, and I'm here with Georgia Howe.
Georgia Howe
Thanks for joining us, John.
John Bickley
Today, we're discussing the opioid epidemic and a novel approach to combating it: psychedelics. Joining me is Daily Wire reporter Tim Pierce. Tim, thanks for being here.
Tim Pierce
Thanks, John.
John Bickley
Tim, how did we get to this point, this official interest in psychedelics?
Tim Pierce
Well, when people hear the word psychedelic, they often think of illicit drug use, but that perception is starting to change, especially in the medical community. Recent studies have shown that psychedelic drugs could have immense benefits in treating drug addiction, PTSD, and other mental health disorders.
John Bickley
That's fascinating. You mentioned one substance in particular, Ibogaine. Can you tell us more about it?
Tim Pierce
Ibogaine is a substance derived from the iboga plant in Africa. Traditionally, it's been used in shamanistic rituals for its hallucinogenic properties, but a growing number of scientists say it's a powerful tool in combating addiction.
John Bickley
I've heard of a scientist named Howard Lotsov who experimented with Ibogaine in the 60s. Can you tell us more about that?
Tim Pierce
Yes, Howard Lotsov took Ibogaine recreationally with six friends who were all heroin users. According to Lotsov, all but one of them saw their heroin addiction disappear overnight with no withdrawal symptoms. This experience led Lotsov to devote his research career to studying the scientific components of the drug.
John Bickley
That's incredible. What kind of studies have been done on Ibogaine since then?
Tim Pierce
There have been several studies, including a 2017 Johns Hopkins study that found 80% of patients who underwent ibogaine treatment eradicated or drastically reduced withdrawal syndrome for a variety of addictions. Another study published in 2018 found that ibogaine significantly reduced cravings among cocaine and opioid users after just one small dose.
John Bickley
That's impressive. How does Ibogaine work in breaking addictive tendencies?
Tim Pierce
Scientists are still trying to understand the exact mechanisms, but it appears that ibogaine rewire serotonin receptors in the brain and restore brain activity to pre-exposure levels. Essentially, it chemically erases addiction pathways in the brain for many users.
John Bickley
That's a game-changer. What's the current state of research on Ibogaine?
Tim Pierce
The drug is still illegal throughout the U.S., but a growing number of Americans are venturing to places like Australia and New Zealand where it's legal. This move paves the way for potential decriminalization, at least in a medical setting.
John Bickley
That's a significant development. What's the reaction from lawmakers?
Tim Pierce
Some states, like Kentucky, are investing in Ibogaine research. Kentucky Attorney General Daniel Cameron introduced a proposal that would allocate $42 million over the next six years to research Ibogaine for treating drug addiction, PTSD, and other mental illnesses.
John Bickley
That's a significant investment. What's the potential impact of this research?
Tim Pierce
If Ibogaine can be clinically validated, it could represent a transformative therapeutic for treating opioid use disorder.
John Bickley
That's a promising development. What about the risks associated with Ibogaine?
Tim Pierce
Yes, there are risks, including potential cardiac toxicity and severe cases of ataxia. However, proponents of the treatment stress that patients must complete a detox from any drugs before taking Ibogaine.
John Bickley
That's an important caveat. What about the spiritual aspects of Ibogaine use?
Tim Pierce
Some users report experiencing a sort of spiritual state during their hallucinations, but many people of religious conviction say using any form of psychedelic drug, even in a medical setting, is essentially playing with fire.
John Bickley
That's a valid concern. Tim, thanks for bringing us up to speed on this fascinating topic.
Tim Pierce
Thanks, John.
John Bickley
And that's a wrap for today's episode of Morning Wire. Thanks for joining us.
Georgia Howe
Thanks for tuning in.
Sound of a news theme plays
John Bickley
If you want to learn more about Ibogaine and the opioid epidemic, check out our show notes for links to the studies and resources we mentioned today.
Georgia Howe
And don't forget to subscribe to Morning Wire for daily coverage of the latest developments in politics, culture, education, sports, and more.
John Bickley
Thanks for listening, and we'll see you tomorrow.
Georgia Howe
Goodnight.
Sound of a news theme fades out